Previous Close | 0.2500 |
Open | 0.2000 |
Bid | 0.0000 |
Ask | 0.2000 |
Strike | 15.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.2000 - 0.3200 |
Contract Range | N/A |
Volume | |
Open Interest | 265 |
VAUGHAN, Ontario, June 17, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of several scientific presentations and educational events during the European Dry Eye Society (EuDEC) 2024 Congress, which will take place in Madrid, Spain, June 20-22.
VAUGHAN, Ontario, June 10, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb INFUSE for Astigmatism daily disposable contact lenses. Engineered with a next-generation lens material infused with ProBalance Technology™ and the company’s proprietary OpticAlign® design, INFUSE for Astigmatism provides astigmatic patients clear, stable vision, all-day comfo
Announced the U.S. launch of Blink NutriTears, a clinically proven over-the-counter supplement that ...